Non-coding recurrent mutations in chronic lymphocytic leukaemia
- PMID: 26200345
- DOI: 10.1038/nature14666
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Abstract
Chronic lymphocytic leukaemia (CLL) is a frequent disease in which the genetic alterations determining the clinicobiological behaviour are not fully understood. Here we describe a comprehensive evaluation of the genomic landscape of 452 CLL cases and 54 patients with monoclonal B-lymphocytosis, a precursor disorder. We extend the number of CLL driver alterations, including changes in ZNF292, ZMYM3, ARID1A and PTPN11. We also identify novel recurrent mutations in non-coding regions, including the 3' region of NOTCH1, which cause aberrant splicing events, increase NOTCH1 activity and result in a more aggressive disease. In addition, mutations in an enhancer located on chromosome 9p13 result in reduced expression of the B-cell-specific transcription factor PAX5. The accumulative number of driver alterations (0 to ≥4) discriminated between patients with differences in clinical behaviour. This study provides an integrated portrait of the CLL genomic landscape, identifies new recurrent driver mutations of the disease, and suggests clinical interventions that may improve the management of this neoplasia.
Comment in
-
Genetic profiling of CLL: a 'TP53 addict' perspective.Cell Death Dis. 2016 Jan 14;7(1):e2042. doi: 10.1038/cddis.2015.415. Cell Death Dis. 2016. PMID: 26775696 Free PMC article. No abstract available.
Similar articles
-
Overview of non-coding mutations in chronic lymphocytic leukemia.Mol Oncol. 2019 Jan;13(1):99-106. doi: 10.1002/1878-0261.12416. Epub 2019 Jan 4. Mol Oncol. 2019. PMID: 30520556 Free PMC article. Review.
-
B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.Hematol Oncol. 2014 Mar;32(1):22-30. doi: 10.1002/hon.2086. Epub 2013 Jul 17. Hematol Oncol. 2014. PMID: 23861036
-
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.Br J Haematol. 2014 Jun;165(5):629-39. doi: 10.1111/bjh.12800. Epub 2014 Mar 2. Br J Haematol. 2014. PMID: 24579978
-
Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome.Sci Rep. 2020 Feb 12;10(1):2407. doi: 10.1038/s41598-020-59243-5. Sci Rep. 2020. PMID: 32051441 Free PMC article.
-
Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.Cancer Genet. 2013 Mar;206(3):49-62. doi: 10.1016/j.cancergen.2013.01.003. Epub 2013 Mar 24. Cancer Genet. 2013. PMID: 23531595 Review.
Cited by
-
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.Nat Commun. 2022 Oct 20;13(1):6220. doi: 10.1038/s41467-022-33739-2. Nat Commun. 2022. PMID: 36266281 Free PMC article.
-
Ribosome specialization in cancer: a spotlight on ribosomal proteins.NAR Cancer. 2024 Jul 9;6(3):zcae029. doi: 10.1093/narcan/zcae029. eCollection 2024 Sep. NAR Cancer. 2024. PMID: 38989007 Free PMC article. Review.
-
miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.Cells. 2023 Dec 30;13(1):84. doi: 10.3390/cells13010084. Cells. 2023. PMID: 38201290 Free PMC article. Review.
-
Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential.Front Oncol. 2022 Oct 18;12:1010506. doi: 10.3389/fonc.2022.1010506. eCollection 2022. Front Oncol. 2022. PMID: 36330491 Free PMC article. Review.
-
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.Nat Genet. 2016 Oct;48(10):1131-41. doi: 10.1038/ng.3659. Epub 2016 Sep 5. Nat Genet. 2016. PMID: 27595477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous